Mirador Capital Partners LP Sells 4,262 Shares of Cardinal Health, Inc. $CAH

Mirador Capital Partners LP trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 30.5% in the 4th quarter, Holdings Channel reports. The firm owned 9,726 shares of the company’s stock after selling 4,262 shares during the quarter. Mirador Capital Partners LP’s holdings in Cardinal Health were worth $1,999,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the stock. Integrated Wealth Concepts LLC lifted its holdings in Cardinal Health by 6.9% during the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock valued at $601,000 after buying an additional 280 shares in the last quarter. Jones Financial Companies Lllp grew its stake in Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after acquiring an additional 14,034 shares in the last quarter. Global Retirement Partners LLC purchased a new position in shares of Cardinal Health during the second quarter worth approximately $556,000. CreativeOne Wealth LLC increased its position in shares of Cardinal Health by 2.5% during the second quarter. CreativeOne Wealth LLC now owns 6,811 shares of the company’s stock worth $1,144,000 after acquiring an additional 167 shares during the period. Finally, Steward Partners Investment Advisory LLC raised its stake in shares of Cardinal Health by 2.7% during the second quarter. Steward Partners Investment Advisory LLC now owns 8,707 shares of the company’s stock valued at $1,463,000 after acquiring an additional 228 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Performance

Cardinal Health stock opened at $206.61 on Friday. The stock has a market cap of $48.62 billion, a PE ratio of 29.73, a price-to-earnings-growth ratio of 1.34 and a beta of 0.65. The stock has a 50-day moving average of $217.41 and a two-hundred day moving average of $196.12. Cardinal Health, Inc. has a one year low of $120.72 and a one year high of $233.60.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Thursday, February 5th. The company reported $2.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.31 by $0.32. The firm had revenue of $65.63 billion for the quarter, compared to the consensus estimate of $64.88 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The company’s revenue for the quarter was up 18.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.93 earnings per share. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Stockholders of record on Wednesday, April 1st will be paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date is Wednesday, April 1st. Cardinal Health’s payout ratio is presently 29.35%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Leerink Partners reiterated an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a report on Monday, March 9th. Evercore lifted their target price on Cardinal Health from $250.00 to $260.00 in a research report on Friday, February 6th. Wall Street Zen cut Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 21st. Barclays raised their price target on Cardinal Health from $243.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, February 24th. Finally, Jefferies Financial Group upped their price objective on shares of Cardinal Health from $220.00 to $270.00 and gave the stock a “buy” rating in a research note on Thursday, January 22nd. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $245.67.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.